P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL)

P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL)

Bibliographic Details
Main Authors:	Armin Ghobadi, Ibrahim Aldoss, Shannon Maude, Alan S Wayne, Deepa Bhojwani, Ashish Bajel, Bhagirathbhai Dholaria, Rawan Faramand, Ryan Mattison, Michael Rettig, Ouiam Bakkacha, John Muth, Angela Pannunzio, Brett Ramsey, Eileen Mcnulty, Matthew Cooper, Jan Davidson-Moncada, Kenneth Jacobs, John Dipersio
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000968336.17893.02

Similar Items

Clinico-biological features and outcome of B- Lymphoblastic Lymphoma (B-LBL) in children
by: K.C. Anand, et al.
Published: (2017-01-01)

PB2498: A PHASE 1 STUDY OF WU-NK-101 IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
by: Amanda Cashen, et al.
Published: (2023-08-01)

P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T-ACUTE LYMPHOBLASTIC LEUKEMIA/T-LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL)
by: F. Ravandi, et al.
Published: (2022-06-01)

Positioning blinatumomab in the frontline of adult B-cell acute lymphoblastic leukemia treatment
by: Hoda Pourhassan, et al.
Published: (2023-08-01)

Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adults
by: Lee KJ, et al.
Published: (2016-08-01)

Study of Extramedullary Lymphoblastic Lymphoma (LBL) Diagnosed by Flowcytometric Immunophenotyping (FCI) on Fine Needle Aspirate (FNA) Sample—A Case Series of 18 Cases
by: Manjiri M Makde, et al.
Published: (2023-01-01)

P356: SUBGROUP ANALYSES OF KTE-X19, AN ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY, IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL) IN ZUMA-3
by: B. D. Shah, et al.
Published: (2022-06-01)

Reversal of glucocorticoid resistance in Acute Lymphoblastic Leukemia cells by miR-145
by: Sili Long, et al.
Published: (2020-06-01)

P392: FEATURES AND TREATMENT OF PATIENTS WITH T(8;14)(Q24;Q11)/ TCRA/D::MYC TRANSLOCATED T ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA (T-ALL/LBL)
by: Xian Zhang, et al.
Published: (2023-08-01)

Timing of Tocilizumab Administration Under the Guidance of IL-6 in CAR-T Therapy for R/R Acute Lymphoblastic Leukemia
by: Yinqiang Zhang, et al.
Published: (2022-06-01)

Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
by: Amber Gibson, et al.
Published: (2021-12-01)

Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
by: Luke Maese, et al.
Published: (2022-06-01)

PB1751: RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKAEMIA (R/R ALL) IN A SINGLE-CENTRE PAEDIATRIC POPULATION
by: Guadalupe Ferreira Gomes, et al.
Published: (2023-08-01)

Experimental study on LBL beams
by: Zhao Chenjie, et al.
Published: (2019-01-01)

Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia
by: Heather A. Ogana, et al.
Published: (2023-03-01)

Acute lymphoblastic leukemia
by: Martin Schrappe
Published: (2018-06-01)

Acute lymphoblastic leukemia
by: Toljić Branka G., et al.
Published: (2023-01-01)

An ensemble-acute lymphoblastic leukemia model for acute lymphoblastic leukemia image classification
by: Mei-Ling Huang, et al.
Published: (2024-01-01)

Dual intra- and extracranial lymphoblastic chloromas in relapsed Pediatric Acute Lymphoblastic Leukemia
by: Kainaat Javed, et al.
Published: (2022-03-01)

Ultrastructural changes in cristae of lymphoblasts in acute lymphoblastic leukemia parallel alterations in biogenesis markers
by: Ritika Singh, et al.
Published: (2021-12-01)

A genetic variant in miR‐100 is a protective factor of childhood acute lymphoblastic leukemia
by: Yao Xue, et al.
Published: (2019-05-01)

miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia
by: Valentina Saccomani, et al.
Published: (2020-07-01)

Changes in Expression of miR-1297 and PTEN Tumor Suppressor Gene in T-cell Acute Lymphoblastic Leukemia
by: Malihe Bagheri, et al.
Published: (2021-01-01)

Acute lymphoblastic leukemia in children
by: M. A. Maschan, et al.
Published: (2022-11-01)

Childhood acute lymphoblastic leukemia
by: G. Mesera, et al.
Published: (2019-09-01)

Osteoporosis in Acute Lymphoblastic Leukemia
by: Lestry Fibriani, et al.
Published: (2019-09-01)

Acute lymphoblastic leukemia in adults
by: Josep-Maria Ribera
Published: (2011-06-01)

Lymphoblastic transformation of myelodysplastic syndrome
by: Carmen Silvia Passos Lima, et al.

MTHFR C677T and TS 5’-UTR 3R/3R Gene Polymorphism in Methotrexate-Resistant Childhood Acute Lymphoblastic Leukemia
by: I Dewa Gede Ugrasena, et al.
Published: (2020-06-01)

Cost Analysis of R-CHOP Versus Dose-Adjusted R-EPOCH in Treatment of Diffuse Large B-Cell Lymphoma with High-Risk Features
by: Bhagirathbhai Dholaria, et al.
Published: (2020-04-01)

Clinical Profile and Induction Outcome of Children with T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma
by: Awais Arshed, et al.
Published: (2022-11-01)

The effect of resveratrol on the expression of MDR1 gene in leukemic lymphoblast’s of acute lymphoblastic leukemia patients
by: Abbasali Hoseinpoor feyzi, et al.
Published: (2015-04-01)

Isatuximab monotherapy in patients with refractory T‐acute lymphoblastic leukemia or T‐lymphoblastic lymphoma: Phase 2 study
by: Nicolas Boissel, et al.
Published: (2022-03-01)

Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia.
by: Mussai, F, et al.
Published: (2010)

Acute myelofibrosis superseding B‐lymphoblastic leukemia/lymphoma
by: Siba El Hussein, et al.
Published: (2023-11-01)

P328: CHARACTERIZATION OF A DUX4-R INHIBITOR AS A POSSIBLE TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA
by: Mara Salomè, et al.
Published: (2023-08-01)

P334: CHARACTERIZATION OF A DUX4-R INHIBITOR AS A POSSIBLE TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA
by: S. Mara, et al.
Published: (2022-06-01)

MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemia
by: Andrea Rzepiel, et al.
Published: (2023-02-01)

MiR-652-5p elevated glycolysis level by targeting TIGAR in T-cell acute lymphoblastic leukemia
by: Shan Liu, et al.
Published: (2022-02-01)

miR-141-3p and TRAF5 Network Contributes to the Progression of T-Cell Acute Lymphoblastic Leukemia
by: Ruiqing Zhou, et al.
Published: (2019-12-01)